Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl) pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide | Patent Number 10167291

US 10167291 B2
Application Number15707508
Publication NumberUS 20180208596 A1
Pendency1 year, 3 months, 15 days
Filled DateSep 18, 2017
Priority DateJul 2, 2015
Publication DateJul 26, 2018
Expiration DateJul 1, 2035
Inventor/ApplicantsTjeerd Barf
Fritz Blatter
Cecile Krejsa
Jerry Evarts
Edwin Aret
Tim Ingallinera
ExaminesWILLIS, DOUGLAS M
Art Unit1624
Technology Center1600
Assignments
Acerta Pharma
Current
Acerta PharmaAstrazeneca
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.